State Street SPDR S&P Pharmaceuticals ETF
XPH
XPH
69 hedge funds and large institutions have $132M invested in State Street SPDR S&P Pharmaceuticals ETF in 2025 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 20 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
3.37% less ownership
Funds ownership: 78.78% → 75.41% (-3.4%)
46% less call options, than puts
Call options by funds: $575K | Put options by funds: $1.06M
Holders
69
Holding in Top 10
–
Calls
$575K
Puts
$1.06M
Top Buyers
| 1 | +$10M | |
| 2 | +$3.21M | |
| 3 | +$2.8M | |
| 4 |
Morgan Stanley
New York
|
+$2.29M |
| 5 |
CI
CX Institutional
Auburn,
Indiana
|
+$2.28M |
Top Sellers
| 1 | -$13.4M | |
| 2 | -$9.62M | |
| 3 | -$4.48M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.19M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$680K |